Novoste Beta-Cath
This article was originally published in The Gray Sheet
Executive Summary
Longer 40 mm radiation source train for the vascular brachytherapy system to treat in-stent restenosis gains FDA approval via PMA supplement. The Beta-Cath system 30 mm source train was approved in November 2000, and an additional supplement is planned for a 60 mm version ("The Gray Sheet" March 26, 2001, p. 5)...